Finding needles in a haystack: dissecting tumor heterogeneity with single-cell transcriptomic and chromatin...

Area of Science:

• Cancer Biology
• Genomics
• Molecular Biology

Background:

• Tumor evolution generates diverse cancer cell types, including epigenetic and gene expression variations not discernible by histology alone.
• Tumor microenvironments are complex, comprising cancer cells, immune cells, and other non-tumor cells, further complicating analysis.
• Traditional bulk genomics methods average molecular profiles, obscuring rare cell subpopulations responsible for therapeutic resistance and metastasis.

Purpose of the Study:

• To review recent advancements in single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq) technologies.
• To highlight the application of these single-cell genomics assays in cancer biology research.
• To demonstrate how scRNA-seq and scATAC-seq enable the dissection of tumor heterogeneity at an unprecedented scale and resolution.

Main Methods:

• Single-cell RNA sequencing (scRNA-seq) for analyzing gene expression at the individual cell level.
• Single-cell ATAC sequencing (scATAC-seq) for assessing chromatin accessibility in individual cells.
• Application of these single-cell technologies to dissect complex cellular subpopulations within tumors.

Main Results:

• scRNA-seq and scATAC-seq allow for the identification and characterization of rare and unique cellular subpopulations within tumors.
• These methods provide high-resolution insights into the epigenetic and gene expression programs driving tumor heterogeneity.
• The detailed analysis of cellular diversity aids in understanding mechanisms of therapeutic resistance and metastatic progression.

Conclusions:

• Single-cell genomics technologies are revolutionizing the study of tumor heterogeneity.
• scRNA-seq and scATAC-seq are crucial tools for unraveling the complexities of cancer cell populations.
• Understanding tumor heterogeneity through single-cell analysis is key to developing more effective cancer therapies.